- Home
- LPCN vs EKSO Comparison
LPCN vs EKSO Comparison
Compare LPCN & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- EKSO
- Stock Information
- Founded
- LPCN 1997
- EKSO 2005
- Country
- LPCN United States
- EKSO United States
- Employees
- LPCN N/A
- EKSO N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- LPCN Health Care
- EKSO Health Care
- Exchange
- LPCN Nasdaq
- EKSO Nasdaq
- Market Cap
- LPCN 16.1M
- EKSO 13.6M
- IPO Year
- LPCN N/A
- EKSO N/A
- Fundamental
- Price
- LPCN $3.16
- EKSO $0.45
- Analyst Decision
- LPCN Strong Buy
- EKSO Strong Buy
- Analyst Count
- LPCN 1
- EKSO 2
- Target Price
- LPCN $10.00
- EKSO $2.50
- AVG Volume (30 Days)
- LPCN 22.1K
- EKSO 204.6K
- Earning Date
- LPCN 05-08-2025
- EKSO 05-05-2025
- Dividend Yield
- LPCN N/A
- EKSO N/A
- EPS Growth
- LPCN N/A
- EKSO N/A
- EPS
- LPCN N/A
- EKSO N/A
- Revenue
- LPCN $3,674,834.00
- EKSO $17,544,000.00
- Revenue This Year
- LPCN N/A
- EKSO $0.20
- Revenue Next Year
- LPCN N/A
- EKSO $42.29
- P/E Ratio
- LPCN N/A
- EKSO N/A
- Revenue Growth
- LPCN N/A
- EKSO N/A
- 52 Week Low
- LPCN $2.75
- EKSO $0.34
- 52 Week High
- LPCN $11.79
- EKSO $1.53
- Technical
- Relative Strength Index (RSI)
- LPCN 48.60
- EKSO 52.84
- Support Level
- LPCN $2.68
- EKSO $0.38
- Resistance Level
- LPCN $3.46
- EKSO $0.53
- Average True Range (ATR)
- LPCN 0.33
- EKSO 0.05
- MACD
- LPCN -0.02
- EKSO -0.00
- Stochastic Oscillator
- LPCN 51.97
- EKSO 48.68
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.